Neogen (NEOG) Construction in Progress (2011 - 2025)
Neogen's quarterly Construction in Progress came in at $186.2 million in Q2 2025, up 63.42% year-on-year from $114.0 million in Q2 2024, and up 63.42% quarter-over-quarter from $114.0 million in Q2 2024.
Neogen has reported Construction in Progress for 15 years, with the latest figure at $186.2 million in Q2 2025.
- For the quarter ending Q2 2025, Construction in Progress rose 63.42% year-over-year to $186.2 million; the trailing twelve-month figure through May 2025 stood at $186.2 million (up 63.42% YoY), and the FY2025 full-year result was $186.2 million, up 63.42% from the prior year.
- Construction in Progress for Q2 2025 stood at $186.2 million, up from $114.0 million in the prior quarter.
- The five-year high for Construction in Progress was $186.2 million in Q2 2025, with the low at $3.3 million in Q2 2021.
- Average Construction in Progress over 5 years is $72.3 million, with a median of $52.2 million recorded in 2023.
- Year-over-year, Construction in Progress plunged 34.36% in 2021 and surged 774.41% in 2023.
- Tracing NEOG's Construction in Progress over 5 years: stood at $3.3 million in 2021, then surged by 83.2% to $6.0 million in 2022, then soared by 774.41% to $52.2 million in 2023, then surged by 118.17% to $114.0 million in 2024, then soared by 63.42% to $186.2 million in 2025.
- The last three Construction in Progress figures came in at $186.2 million (Q2 2025), $114.0 million (Q2 2024), and $52.2 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 509.50 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 186.24 Mn |
| May 31, 2024 | 113.97 Mn |
| May 31, 2023 | 52.24 Mn |
| May 31, 2022 | 5.97 Mn |
| May 31, 2021 | 3.26 Mn |
| May 31, 2020 | 4.97 Mn |
| May 31, 2019 | 2.29 Mn |
| May 31, 2018 | 2.65 Mn |
| May 31, 2017 | 2.29 Mn |
| May 31, 2016 | 1.06 Mn |
| May 31, 2015 | 783,000.00 |
| May 31, 2014 | 1.66 Mn |
| May 31, 2013 | 1.56 Mn |
| May 31, 2012 | 590,000.00 |
| May 31, 2011 | 1.22 Mn |